title: A view to natural killer cells in hepatitis C.
authors.forename: Naglaa H
authors.initials: NH
authors.lastname: Shoukry
authors.forename: Sandy
authors.initials: S
authors.lastname: Pelletier
authors.forename: Kyong-Mi
authors.initials: KM
authors.lastname: Chang
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects*; D016898:Interferon-alpha / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects*; D008099:Liver / Q000187:drug effects*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a